Welcome to LookChem.com Sign In|Join Free

CAS

  • or

22620-34-4

22620-34-4

Post Buying Request

22620-34-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

22620-34-4 Usage

Uses

(5-Chloro-3-Pyridinyl)Methanol is used in preparation of piperidines or piperidones substituted with urea and heteroaryl as FPR2 modulators.

Check Digit Verification of cas no

The CAS Registry Mumber 22620-34-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,6,2 and 0 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 22620-34:
(7*2)+(6*2)+(5*6)+(4*2)+(3*0)+(2*3)+(1*4)=74
74 % 10 = 4
So 22620-34-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H6ClNO/c7-6-1-5(4-9)2-8-3-6/h1-3,9H,4H2

22620-34-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name (5-Chloro-3-pyridinyl)methanol

1.2 Other means of identification

Product number -
Other names (5-chloropyridin-3-yl)methanol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:22620-34-4 SDS

22620-34-4Relevant articles and documents

SUBSTITUTED DIAMINOPYRIMIDYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH

-

Paragraph 0321, (2015/07/02)

Provided herein are diaminopyrimidyl Compounds having the following structures: wherein X, L, R1, and R2 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidyl Compound, and methods for treating or preventing PKC-theta-mediated disorders, or a condition treatable or preventable by inhibition of a kinase, for example, PKC-theta.

Benzamides

-

Paragraph 0124, (2014/05/07)

The present invention is directed to benzamide containing compounds which inhibit the P2X7 receptor

Potential hypolipidemic agents. II. Preparation of 5-halo-3-pyridylmethanols.

Hedbom,Helgstrand,Misiorny,Stjernstroem,Westin

, p. 259 - 260 (2007/10/04)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 22620-34-4